New diabetes clinical trial: Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis

Published on: April 09, 2019 at 09:30PM
Conditions:   Diabetic Nephropathy Type 2;   Type2 Diabetes
Interventions:   Device: Continuous glucose monitoring;   Diagnostic Test: Glycaemic markers;   Radiation: Erythrocyte life span;   Device: Carbon monoxide (CO)-rebreathing method
Sponsors:   Rigshospitalet, Denmark;   Steno Diabetes Center
Recruiting
http://bit.ly/2uVmZ5a